COLORECTAL CANCER IN RELATION TO POSTMENOPAUSAL ESTROGEN AND ESTROGEN PLUS PROGESTIN IN THE WOMEN'S HEALTH INITIATIVE CLINICAL TRIAL AND OBSERVATIONAL STUDY

BACKGROUND: Colorectal cancer incidence was reduced among women assigned to active treatment in the Women's Health Initiative (WHI) estrogen plus progestin randomized trial, but the interpretation was obscured by an associated later stage of diagnosis. In contrast the estrogen-alone trial showe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Prentice, Ross L., Pettinger, Mary, Beresford, Shirley A. A., Wactawski-Wende, Jean, Hubbell, F. Allan, Stefanick, Marcia L., Chlebowski, Rowan T.
Format: Article
Idioma:English
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689377/
https://ncbi.nlm.nih.gov/pubmed/19423530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-08-1209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2689377/
https://ncbi.nlm.nih.gov/pubmed/19423530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-08-1209

Ítems similars